US FDA extends review of KalVista's swelling disorder drug due to heavy workload-June 2024-www.financetom.com

US FDA extends review of KalVista's swelling disorder drug due to heavy workload

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA extends review of KalVista's swelling disorder drug due to heavy workload

Jun 13, 2025 1:37 PM

June 13 (Reuters) - The U.S. Food and Drug

Administration extended the review of KalVista Pharmaceuticals' ( KALV )

drug for a type of hereditary swelling disorder due to

heavy workload and limited resources, the company said on

Friday.

The FDA indicated that it expects to deliver a decision

within approximately four weeks, KalVista said.

Previous page： Talkspace Shares Jump After Launching Partnership With Amazon Health Services Next page： UK's VivoPower to combine with Canadian hydrogen technology firm in $1.13 bln deal

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Talkspace Shares Jump After Launching Partnership With Amazon Health Services

Sep 17, 2024

09:56 AM EDT, 09/17/2024 (MT Newswires) -- Talkspace ( TALK ) shares jumped past 15% in recent Tuesday trading after the company said it's launching a partnership with Amazon.com's ( AMZN ) Amazon Health Services to raise awareness of its mental health care services on Amazon ( AMZN ). Under the partnership, Amazon ( AMZN ) will help customers discover,...

UK's VivoPower to combine with Canadian hydrogen technology firm in $1.13 bln deal

Sep 17, 2024

Sept 17 (Reuters) - Power infrastructure developer VivoPower International ( VVPR ) said on Tuesday it has signed a non-binding agreement to merge with Canada's Future Automotive Solutions and Technologies (FAST), which would create a $1.13 billion combined company. The agreement values VivoPower's ( VVPR ) equity at $556 million and FAST at $578 million, and allows the companies an...

Carlyle to Buy $300 Million in Equity Sharing Home Loans From Unison

Sep 17, 2024

09:54 AM EDT, 09/17/2024 (MT Newswires) -- Carlyle Group ( CG ) said Tuesday it has agreed to buy up to $300 million in equity sharing home loans from Unison and to make a strategic investment in the company. Unison's new equity sharing home loan combines home loans with equity sharing agreements, allowing homeowners to convert home equity into cash...

RTX Says Unit Awarded Contract for Project to Streamline Radar Production for US Navy Program

Sep 17, 2024

09:51 AM EDT, 09/17/2024 (MT Newswires) -- RTX (RTX) said its Raytheon subsidiary has been awarded a new contract by the Office of Naval Research to assist with a project to streamline and automate the production of transmit and receive modules used in the US Navy's SPY-6 radar systems. Financial details of the contract weren't disclosed. Work on the new...